Jane Street Group, LLC Acquires 6.4% Passive Stake in Co-Diagnostics, Inc. (CODX)

On June 3, 2026, Jane Street Group, LLC filed a Schedule 13G with the SEC, reporting a significant passive ownership stake in Co-Diagnostics, Inc. (CODX). As of the event date on May 28, 2026, the firm and its subsidiaries, Jane Street Capital, LLC and Jane Street Global Trading, LLC, collectively hold 236,359 shares of common stock. This position represents a 6.4% ownership interest in the company. The filing indicates that Jane Street Group, LLC maintains shared voting and dispositive power over the entire 236,359 shares. Specifically, Jane Street Capital, LLC holds 189,817 shares (5.2%), while Jane Street Global Trading, LLC holds 46,542 shares (1.3%). The acquisition was made in the ordinary course of business and not for the purpose of influencing or changing the control of the issuer. This filing marks a notable increase in holdings compared to previous reports, crossing the 5% regulatory threshold required for Schedule 13G disclosure.